ARCHIVES

AACR Says 5 Percent Of Meeting Registrants Couldn’t Attend Due To Volcanic Ash In Europe

This article is from The Cancer Letter archive.

Vol. 36 No. 16 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Accelerated Approval For Adcetris For Two Lymphoma Indications

July 22, 2011

Guest Editorial By ACS Chief Medical Officer Otis Brawley: ACS Revises Process for Making Guidelines

January 13, 2012

Leukemia Biology Study Needed To Improve Results, Pinkel Says In Karnfsky Lecture

April 7, 1978

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

MM-121 Study Fails PFS Endpoint, Biomarker Analysis Continues

November 29, 2013

Dingell Asks FDA To Explain Failure To Curtail ESA Ads.

June 15, 2007